2023
Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut
Dowton A, Doernberg M, Heiman E, Barelli P, Golden M, Wang H, Leventhal J, Morford K, Sue K. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal Of Addiction Medicine 2023, 17: 739-741. PMID: 37934550, DOI: 10.1097/adm.0000000000001198.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersDrug useCase report presentsIndex of suspicionInjection drug useDrug supplyCare management strategiesHarm reduction strategiesOverdose presentationsCutaneous manifestationsWithdrawal syndromeClinical complicationsCase reportIntravenous useWound carePatientsTreatment of woundsInfectious diseasesChronic woundsXylazineSkin woundsWoundsMore reportingDiagnosisChanging approaches to treating opioid withdrawal in the USA
Hughes M, Edinoff A, Sue K. Changing approaches to treating opioid withdrawal in the USA. The Lancet Psychiatry 2023, 10: 378-380. PMID: 37167986, DOI: 10.1016/s2215-0366(23)00145-1.Commentaries, Editorials and LettersPerspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
Sue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineEmergency Service, HospitalFemaleHealth ServicesHumansMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersConceptsCommunity-based cliniciansOpioid use disorderEmergency departmentOUD treatmentMedication treatmentSubstance use disorders trainingUrban academic emergency departmentEffectiveness-implementation studyAcademic emergency departmentDisorder treatment settingsPerspectives of cliniciansCommunity-based treatmentCommunity-based treatment programsStaff perspectivesImplementation science frameworkBuprenorphine programTreatment cliniciansPeer navigatorsReferral sitesPromoting ActionMAIN OUTCOMEED staffBuprenorphineFocus groupsUse disorders
2022
Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection
Rosen J, Glick J, Zhang L, Cooper L, Olatunde P, Pelaez D, Rouhani S, Sue K, Park J. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction 2022, 118: 847-854. PMID: 36468191, PMCID: PMC10073256, DOI: 10.1111/add.16103.Peer-Reviewed Original ResearchMeSH KeywordsAdultCross-Sectional StudiesDrug OverdoseFemaleHarm ReductionHumansNaloxoneOpioid-Related DisordersSubstance Abuse, IntravenousConceptsThreat of violenceCross-sectional qualitative studyDepth interviewsHarm reduction strategiesPublic spaceOverdose riskDrug useThematic analysisQualitative studyEmergent designSocial environmentRisk environmentNaloxone possessionBaltimore CityInterviewsWWIDReduction strategiesOpioid withdrawalViolenceFatal overdoseStreet interceptUsing a structural vulnerability framework to understand the impact of COVID‐19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City
Zhen‐Duan J, Gade N, Falgas‐Bagué I, Sue KL, DeJonckheere M, Alegría M. Using a structural vulnerability framework to understand the impact of COVID‐19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City. Health Services Research 2022, 57: 1104-1111. PMID: 35340033, PMCID: PMC9111318, DOI: 10.1111/1475-6773.13975.Peer-Reviewed Original ResearchMeSH KeywordsAdultCOVID-19EthnicityHumansMedicaidMinority GroupsNew York CityOpioid-Related DisordersPandemicsUnited StatesConceptsNew York CityLow-income individualsStructural vulnerabilityPrimary qualitative dataDepth qualitative interviewsQualitative research approachCOVID-19 pandemicThematic analysis approachYork CityDepth interviewsEconomic disparitiesQualitative interviewsVulnerability frameworkEthnic minority adultsFood insecurityStructural competencyQualitative dataSocial relationshipsHousing conditionsThematic analysisCommunity resourcesResearch approachCOVID-19Theoretical frameworkHome ordersA Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era
Sue KL, Cohen S, Tilley J, Yocheved A. A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era. Journal Of Addiction Medicine 2022, 16: 389-391. PMID: 35020693, DOI: 10.1097/adm.0000000000000952.Commentaries, Editorials and LettersMeSH KeywordsAnalgesics, OpioidBuprenorphineDrug OverdoseFentanylHumansOpioid-Related DisordersUnited StatesHarm Reduction in Health Care Settings
Chan CA, Canver B, McNeil R, Sue KL. Harm Reduction in Health Care Settings. Medical Clinics Of North America 2022, 106: 201-217. PMID: 34823731, DOI: 10.1016/j.mcna.2021.09.002.Peer-Reviewed Original ResearchMeSH KeywordsAlcohol DrinkingAnalgesics, OpioidBehavior, AddictiveCentral Nervous System StimulantsCounselingDelivery of Health CareDrug OverdoseFentanylHarm ReductionHumansInfection ControlMaleNaloxoneNarcotic AntagonistsNarcoticsOpioid-Related DisordersPre-Exposure ProphylaxisSubstance-Related Disorders
2021
Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic
Essien UR, Ifidon A, Sue KL. Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic. Journal Of Hospital Medicine 2021, 16: 638-639. PMID: 34613902, PMCID: PMC8494278, DOI: 10.12788/jhm.3703.Commentaries, Editorials and LettersBringing Harm Reduction into Health Policy — Combating the Overdose Crisis
Sue KL, Fiellin DA. Bringing Harm Reduction into Health Policy — Combating the Overdose Crisis. New England Journal Of Medicine 2021, 384: 1781-1783. PMID: 33983692, DOI: 10.1056/nejmp2103274.Commentaries, Editorials and Letters